October 16, 2012 at 11:34 AM EDT
Threshold (THLD) strikes deal, stocks leap
Normal 0 false false false MicrosoftInternetExplorer4 Threshold Pharmaceuticals Inc. (NASDAQ: THLD) shares rose 4.8% to $5.50 after the firm said it has reached an agreement with a U.S. affiliate of Merck Kgaa to develop a new treatment for cancer patients. Threshold traded in 1.4 million shares. /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here